Tumour necrosis factor |[alpha]| polymorphism (|[minus]|1031T|[sol]|C) is associated with age of onset of schizophrenia
xiang yang zhang,colin n haile,yun long tan,L J Zuo,B Z Yang,lian yuan cao,dong feng zhou
DOI: https://doi.org/10.1038/sj.mp.4001710
IF: 11
2005-01-01
Molecular Psychiatry
Abstract:SIR—Tumour necrosis factor alpha (TNF-) is an important cytokine that plays a key role in inflammation and immunity. It is produced in the central nervous system where it participates in nerve-cell growth, differentiation and mediates synaptic integrity.1 TNF- is increased in serum in schizophrenic patients and correlates with total BPRS and Scale Assessment of Positive Symptoms scores in schizophrenia.2 TNF- may modulate the prodromal, acute, and residual phases of schizophrenia as well as influence response to treatment.2 Increased TNF- release in patients is normalized with antipsychotic treatment.3 Thus, aberrant TNF- may play a role in the pathogenesis and/or psychopathological symptoms in schizophrenia. Studies have shown an association between the -G308A TNF- polymorphism and schizophrenia,4, 5 although other studies do not replicate the result.6 The TNF- gene is located right within the class III region of the major histocompatibility complex (MHC) on chromosome 6p21.3, a region associated with genetic susceptibility to schizophrenia.7 Wilson et al8 reported that a polymorphism (A–G) at position -308 in the promoter region of the TNF- gene is associated with increased rate of transcription. This evidence has led to the hypothesis that a genetically determined increase in TNF- production could increase susceptibility to developing schizophrenia.4 Therefore, we investigated whether a T/C polymorphism at position -1031 in the promoter region of the TNF- was associated with onset of schizophrenia. A total of 111 inpatients (69 men and 42 women) meeting the DSM-IV criteria for schizophrenia and unrelated 146 healthy controls (94 men and 52 women) were included in the study. All patients were chronically ill (mean duration of illness 21.29.9 years). Normal controls were recruited from the local community, and matched for age and gender. All subjects were Han Chinese and came from the Beijing area and gave signed informed consent to participate. The study was approved by Peking University's Institutional Review Board, Institute of Mental Health. Blood samples were drawn and genomic DNA extracted. The -1031T/C polymorphism was genotyped using the method described previously9 and was carried out blind to the clinical status. Genotype frequency distributions, genotype, and allelic frequencies did not differ between patients and controls. No interaction was found between sex and genotypes. Table 1 shows the relationships between TNF- genotype and clinical variables in schizophrenia patients. Age of onset significantly differed between the genotype groups (P=0.012). Age of onset was defined as the age at which the psychotic symptoms first appeared, according to medical case notes and interviews. Multiple regression revealed that the number of -1031C alleles (0,1,2) was parametrically related to age of onset after adding age and gender to the regression analysis (r2=0.06, P=0.017). TNF- genotype accounted for 6% of the variance. To further confirm this relationship we expanded the number of patients to 230. An association between the –1031T/C genotypes and age of onset increased in significance (T/T, 24.16.0 years, n=151; T/C, 25.88.1 years, n=57; C/C, 30.510.5 years, n=22) (F=7.61, df=2, 227, P=0.001). Our results demonstrate that the –1031T/C polymorphism of the TNF- gene is associated with age of onset of schizophrenia and provides further support for a relationship between this disease and aberrant TNF- gene structure. This is consistent with other studies showing that TNF- polymorphisms are associated with some aspect of schizophrenia.4, 5 A direct effect of the TNF- -1031T/C polymorphism itself may have contributed toward the present findings. Polymorphisms in the promoter region of the TNF- gene affect TNF- gene expression and protein production.10 Abnormal levels of TNF- at critical times in development may render individuals susceptible to schizophrenia.4, 5 Other polymorphisms (-308G/A) are associated with elevated serum concentrations of TNF-8 and schizophrenia but not bipolar disorder.5 These effects may also be due to linkage disequilibrium between this polymorphism and a functional polymorphism in or near the TNF- gene. The TNF- gene is located within the MHC, which is gene-dense and a highly polymorphic region, with the TNF- gene itself containing a large number of polymorphisms.10 Moreover, the MHC region is known to exhibit extensive linkage disequilibrium across the whole region. In summary, although the mechanisms by which the -1031T/C genotype exerts its effects are still obscure, our results demonstrated for the first time that age of onset was associated with the TNF- -1031T/C polymorphism. These results add to other findings showing aberrant TNF- is associated with various aspects of schizophrenia.